Protagonist Therapeutics (PTGX) Enterprise Value: 8.071B

Protagonist Therapeutics, Inc. (PTGX)

136.24 +0.34 (+0.25%) USD | NASDAQ | Nov 10, 16:00

136.24 0.00 (0.00%) After-Hours: 17:51

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2016. Start Trial.

Date	Value
November 09, 2026	8.071B
November 06, 2026	7.820B
November 05, 2026	8.030B
November 04, 2026	8.559B
November 03, 2026	8.354B
November 02, 2026	8.298B
October 30, 2026	8.655B
October 29, 2026	8.622B
October 28, 2026	8.478B
October 27, 2026	8.412B
October 26, 2026	8.360B
October 23, 2026	8.236B
October 22, 2026	8.308B
October 21, 2026	8.214B
October 20, 2026	8.208B
October 19, 2026	7.976B
October 16, 2026	7.605B
October 15, 2026	8.114B
October 14, 2026	8.096B
October 13, 2026	8.240B
October 12, 2026	8.657B
October 09, 2026	8.582B
October 08, 2026	8.333B
October 07, 2026	8.399B
October 06, 2026	8.253B

Date	Value
October 05, 2026	8.380B
October 02, 2026	8.343B
October 01, 2026	8.286B
September 30, 2026	8.397B
September 29, 2026	8.343B
September 28, 2026	8.439B
September 25, 2026	8.401B
September 24, 2026	8.109B
September 23, 2026	8.197B
September 22, 2026	8.609B
September 21, 2026	8.603B
September 18, 2026	8.475B
September 17, 2026	8.520B
September 16, 2026	8.464B
September 15, 2026	8.501B
September 14, 2026	8.784B
September 11, 2026	8.810B
September 10, 2026	8.614B
September 09, 2026	8.610B
September 08, 2026	8.665B
September 04, 2026	8.651B
September 03, 2026	8.850B
September 02, 2026	8.674B
September 01, 2026	8.700B
August 31, 2026	8.782B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks